Robbinsville, NJ, United States of America

John K Thottathil

USPTO Granted Patents = 64 

 

 

Average Co-Inventor Count = 1.9

ph-index = 11

Forward Citations = 325(Granted Patents)

Forward Citations (Not Self Cited) = 291(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Lawrenceville, NJ (US) (1988 - 1989)
  • Trenton, NJ (US) (1985 - 1990)
  • Princeton, NJ (US) (1998 - 2001)
  • Robbinsville, NJ (US) (1990 - 2007)
  • Mudelein, IL (US) (2016)
  • Mundelein, IL (US) (2014 - 2020)
  • Ivanhoe, IL (US) (2003 - 2021)

Company Filing History:


Years Active: 1985-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Opioid Abuse Prevention
Alpha-Hydroxy Carboxylic Acid
GRAS Prodrugs
Taxane Compounds
Antiviral Agents
Beta-Lactams
Biphenyl Isoxazole Sulfonamides
Prostaglandin Analog Intermediates
Dioxane Derivatives
Enzymatic Reduction
Phosphonyloxyacyl Amino Acids
Microbiological Hydrolysis
64 patents (USPTO):Explore Patents

Title: John K. Thottathil: Innovator in Opioid Abuse Prevention

Introduction

John K. Thottathil, based in Robbinsville, NJ, is a notable inventor specializing in pharmaceutical innovations, particularly in the area of opioid abuse prevention. With an impressive portfolio of 64 patents, Thottathil has made significant contributions to drug delivery systems and compositions aimed at combating the opioid crisis.

Latest Patents

Among his latest innovations, Thottathil has developed methods and compositions for preventing opioid abuse, including abuse-resistant opioid compounds and drug delivery systems. His patents emphasize pharmaceutical formulations where opioids are covalently bound to chemical moieties, alongside methods for effective delivery of active ingredients to subjects. These innovations play a critical role in addressing the pressing issue of opioid dependency and enhancing patient safety.

Career Highlights

Throughout his career, John K. Thottathil has worked with reputable companies, notably at E.R. Squibb & Sons, Inc. and Bristol-Myers Squibb Company. His experience in these organizations has allowed him to refine his skills in pharmaceutical research and development, driving forward innovative solutions in medication design and efficacy.

Collaborations

Thottathil’s work has been enriched through collaborations with esteemed colleagues such as Wen-Sen Li and David R. Kronenthal. Their combined expertise has contributed to the successful advancement of innovative projects and research initiatives aimed at improving healthcare solutions.

Conclusion

John K. Thottathil's contributions to the field of pharmaceuticals are invaluable, particularly in the realm of opioid abuse prevention. His numerous patents reflect his dedication to innovation and his commitment to creating safer medical treatments. As the opioid crisis continues to challenge healthcare systems, Thottathil’s work remains crucial in the pursuit of effective solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…